These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9681764)

  • 1. Successful treatment of anaemia of nephrotic syndrome with recombinant human erythropoietin.
    Bayés B; Serra A; Juncà J; Lauzurica R
    Nephrol Dial Transplant; 1998 Jul; 13(7):1894-5. PubMed ID: 9681764
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant human erythropoietin for anaemia in nephrotic syndrome with thalassemia.
    Ng YY; Liu SM; Chadban S; Lan HY; Huang TP
    Clin Nephrol; 1997 Apr; 47(4):273-4. PubMed ID: 9128797
    [No Abstract]   [Full Text] [Related]  

  • 3. [Urinary erythropoietin excretion: an unknown cause of anemia during nephrotic syndrome].
    Terrier B; Fakhouri F; Sultanik P; Delarue R; Hummel A
    Rev Med Interne; 2006 Aug; 27(8):643-5. PubMed ID: 16876918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of anemia of nephrotic syndrome with recombinant erythropoietin.
    Gansevoort RT; Vaziri ND; de Jong PE
    Am J Kidney Dis; 1996 Aug; 28(2):274-7. PubMed ID: 8768925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful erythropoietin treatment for severe anemia in nephrotic syndrome without renal dysfunction.
    Ishimitsu T; Ono H; Sugiyama M; Asakawa H; Oka K; Numabe A; Abe M; Matsuoka H; Yagi S
    Nephron; 1996; 74(3):607-10. PubMed ID: 8938689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current thinking and treatment practices in anaemia--an interactive poll.
    Spivak JL; Cazzola M
    Med Oncol; 2000 Nov; 17 Suppl 1():S32-7. PubMed ID: 11188784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human erythropoietin (rHuEPO) therapy in patients with cancer-related anaemia: what have we learned?
    Osterborg A
    Med Oncol; 1998 Aug; 15 Suppl 1():S47-9. PubMed ID: 9785337
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful treatment of anemia in idiopathic myelofibrosis with recombinant human erythropoietin.
    Hasselbalch HC; Clausen NT; Jensen BA
    Am J Hematol; 2002 Jun; 70(2):92-9. PubMed ID: 12111781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin deficiency causes anemia in nephrotic children with normal kidney function.
    Stuart M
    Clin Pediatr (Phila); 2002 Jun; 41(5):361. PubMed ID: 12086203
    [No Abstract]   [Full Text] [Related]  

  • 10. [Erythropoietin treatment for late anaemia after haemolytic disease of the newborn].
    Alvarez Domínguez E; Pérez Fernández JM; Figueras Aloy J; Carbonell Estrany X
    An Pediatr (Barc); 2010 Dec; 73(6):334-9. PubMed ID: 20970396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human erythropoietin in the anaemia of multiple myeloma and non-Hodgkin's lymphoma.
    San Miguel JF; García-Sanz R
    Med Oncol; 1998 Aug; 15 Suppl 1():S29-34. PubMed ID: 9785334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin therapy: need for rationality and active surveillance.
    Cazzola M
    Haematologica; 2003 Jun; 88(6):601-5. PubMed ID: 12801832
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anaemia, cardiac failure and erythropoietin].
    Cohen Solal A; Beauvais F
    Arch Mal Coeur Vaiss; 2005 Oct; 98(10):997-1001. PubMed ID: 16294546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neonatal anaemia secondary to rhesus incompatibility treated by recombinant erythropoietin].
    Kayemba-Kay's S; Christin P; Yahouanc-Lapalle H; Oriot D
    Arch Pediatr; 2004 Jul; 11(7):868-9. PubMed ID: 15234390
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of anaemia with rHuEpo in patients with MDS.
    Casadevall N
    Med Oncol; 1998 Aug; 15 Suppl 1():S35-7. PubMed ID: 9785335
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of human erythropoietin (hEPO) treatment on anemia in ICR-derived glomerulonephritis (ICGN) mice.
    Miyamoto Y; Kuramitsu-Miyamoto K; Iwanaga E; Uchio-Yamada K; Yamaguchi-Yamada M; Ogura A; Manabe N
    Exp Anim; 2005 Apr; 54(2):181-4. PubMed ID: 15897628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy-resistant anaemia in congenital nephrotic syndrome of the Finnish type--implication of EPO, transferrin and transcobalamin losses.
    Toubiana J; Schlageter MH; Aoun B; Dunand O; Vitkevic R; Bensman A; Ulinski T
    Nephrol Dial Transplant; 2009 Apr; 24(4):1338-40. PubMed ID: 19153070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Response to recombinant human erythropoietin of anemia secondary to pressure ulcers in a patient with multiple sclerosis].
    Sánchez Marín B; Grasa JM; García Erce JA; Pérez Lungmus G
    Rev Neurol; 2001 Nov 16-30; 33(10):997-8. PubMed ID: 11785020
    [No Abstract]   [Full Text] [Related]  

  • 19. Erythropoietin-deficient anemia associated with autoimmune polyglandular syndrome type I.
    Toonkel R; Levine M; Gardner L
    Am J Hematol; 2004 Feb; 75(2):84-8. PubMed ID: 14755373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypothyroidism and resistance to human recombinant erythropoietin.
    Touam M; Guéry B; Goupy C; Menoyo V; Drüeke T
    Nephrol Dial Transplant; 2004 Apr; 19(4):1020-1. PubMed ID: 15031379
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.